These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 22302327

  • 1. Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.
    Fullerton CA, Epstein AM, Frank RG, Normand SL, Fu CX, McGuire TG.
    Psychiatr Serv; 2012 Feb 01; 63(2):115-21. PubMed ID: 22302327
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program.
    Constantine RJ, Tandon R, McPherson M, Andel R.
    J Child Adolesc Psychopharmacol; 2011 Feb 01; 21(1):79-84. PubMed ID: 21288122
    [Abstract] [Full Text] [Related]

  • 4. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
    Winterstein AG, Soria-Saucedo R, Gerhard T, Correll CU, Olfson M.
    J Clin Psychiatry; 2017 Jul 01; 78(7):e744-e781. PubMed ID: 28686819
    [Abstract] [Full Text] [Related]

  • 5. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
    Comer JS, Olfson M, Mojtabai R.
    J Am Acad Child Adolesc Psychiatry; 2010 Oct 01; 49(10):1001-10. PubMed ID: 20855045
    [Abstract] [Full Text] [Related]

  • 6. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA, Sikirica V, Hodgkins P, Zhou Z, Xie J, DeLeon A, Erder MH, Wu EQ.
    J Child Adolesc Psychopharmacol; 2014 Jun 01; 24(5):260-8. PubMed ID: 24839998
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
    Chen CY, Gerhard T, Winterstein AG.
    J Child Adolesc Psychopharmacol; 2009 Apr 01; 19(2):187-95. PubMed ID: 19364296
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends.
    Girand HL, Litkowiec S, Sohn M.
    Pediatrics; 2020 Jul 01; 146(1):. PubMed ID: 32487590
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prescribing for young people with attention deficit hyperactivity disorder in UK primary care: analysis of data from the Clinical Practice Research Datalink.
    Newlove-Delgado T, Hamilton W, Ford TJ, Stein K, Ukoumunne OC.
    Atten Defic Hyperact Disord; 2019 Sep 01; 11(3):255-262. PubMed ID: 30730035
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R, Liu C, Bolognani F.
    Autism Res; 2018 Dec 01; 11(12):1690-1700. PubMed ID: 30380202
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
    Khanna R, Jariwala K, West-Strum D.
    J Intellect Disabil Res; 2013 Feb 01; 57(2):161-71. PubMed ID: 22471524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.